Biliary bypass for ductal adenocarcinoma of the pancreas: Mayo Clinic experience, 1970-1975.
During a recent 6-year period at the Mayo Clinic, 151 biliary bypass procedures for ductal adenocarcinoma of the pancreas were done, with operative mortality of 6.0% and an acceptable operative morbidity. Relief of jaundice was universal among survivors. Median survival was 6.0 months, and 3-year survival was 2%. These figures are compared with those for resective procedures.
D000328:Adult; D000368:Aged; D001662:Biliary Tract Surgical Procedures; D002285:Carcinoma, Intraductal, Noninfiltrating / Q000401:mortality / Q000601:surgery*; D002763:Cholecystectomy; D003135:Common Bile Duct / Q000601:surgery; D004386:Duodenum / Q000601:surgery; D005260:Female; D005500:Follow-Up Studies; D005774:Gastrostomy; D006801:Humans; D007422:Intestines / Q000601:surgery; D007583:Jejunum / Q000601:surgery; D008099:Liver / Q000601:surgery; D008297:Male; D008722:Methods; D008875:Middle Aged; D010190:Pancreatic Neoplasms / Q000401:mortality / Q000601:surgery*